Christophe Deben
Professor University of Antwerp, co-founder DrugVision.AI and Orbits Oncology platforms
University of Antwerp
Antwerp, Belgium
Prof. Dr. Christophe Deben, advancing high-throughput tumor organoid drug screening with AI-driven live-cell imaging.
About me
Group lead Tumoroid Screening Lab (University of Antwerp)
Head of UZA/UAntwerp tumor organoid biobank
Head of DrugVision.AI drug screening platform (www.drugvision.ai, University of Antwerp)
Co-founder Orbits Oncology image and data analysis platform for high-throughput organoid drug screening (www.orbits-oncology.com, spin-off University of Antwerp)
Co-founder Sightera Biosciences for AI drug development (www.sightera-biosciences.com, spin-off in development University of Antwerp)
My organisation
Sector: Chemicals, Pharmaceuticals and Life sciences
Skills
- Tumor Organoids
- Cancer research
- Live-cell imaging
- High-throughput drug screening
Interests
- AI in translational cancer research
- High-throughput drug screening
Speaker sessions (1)
Monday, 17 June 2024
13:15 - 15:15